Back to Clinical Trial Search

Clinical Trial

Study Assessing the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Cancer Type

Siteman Kids- Pediatrics

Protocol Number

202511021

Principal Investigator

Sisk, Bryan

Learn more about this study at clinicaltrials.gov

For more information contact us here:

Phone

800-600-3606

Email

[email protected]

Brief Summary

This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS).

Protocol Interventions

Drug: Alpelisib
Learn About Clinical Trials

Clinical trials are research studies that help us find new ways to prevent, diagnose, and treat cancer. If you are interested in participating in a clinical trial, our team will help you find a study that is right for you. Call us to speak with a Siteman care coordinator.

Call Us Refer a Patient